Bioasis Technologies Stock Today

BTI Stock  CAD 1.19  0.01  0.83%   

Performance

9 of 100

 
Weak
 
Strong
OK

Odds Of Distress

Over 53

 
High
 
Low
Average
British Amer is selling for under 1.19 as of the 18th of July 2024; that is 0.83 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.19. British Amer has 53 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for biOasis Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 18th of June 2024 and ending today, the 18th of July 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company was founded in 2007 and is based in New Haven, Connecticut. The company has 79.41 M outstanding shares of which 105.04 K shares are currently shorted by private and institutional investors with about 0.01 days to cover all short positions. More on biOasis Technologies

Moving together with British Stock

  0.65AAPL Apple Inc CDRPairCorr
  0.62JPM JPMorgan ChasePairCorr

British Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. British Amer's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding British Amer or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ChairmanDeborah Rathjen
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
British Amer's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to British Amer's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
British Amer can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand British Amer's financial leverage. It provides some insight into what part of British Amer's total assets is financed by creditors.
Liquidity
British Amer cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. biOasis Technologies has accumulated 1.9 M in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. biOasis Technologies has a current ratio of 1.67, which is within standard range for the sector. Debt can assist British Amer until it has trouble settling it off, either with new capital or with free cash flow. So, British Amer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like biOasis Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for British to invest in growth at high rates of return. When we think about British Amer's use of debt, we should always consider it together with cash and equity.

Other Non Cash Items

51,322.95
biOasis Technologies (BTI) is traded on TSX Venture Exchange in Canada and employs 15 people. British Amer is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 397.07 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate British Amer's market, we take the total number of its shares issued and multiply it by British Amer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. biOasis Technologies classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 79.41 M outstanding shares of which 105.04 K shares are currently shorted by private and institutional investors with about 0.01 days to cover all short positions. biOasis Technologies has accumulated about 2.68 M in cash with (3.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check British Amer Probability Of Bankruptcy
Ownership Allocation
biOasis Technologies retains a total of 79.41 Million outstanding shares. Nearly 98.0 percent of British Amer outstanding shares are held by general public with 2.05 (percent) owned by insiders and only 0.0 % by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check British Ownership Details

biOasis Technologies Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. British Amer market risk premium is the additional return an investor will receive from holding British Amer long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in British Amer. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although British Amer's alpha and beta are two of the key measurements used to evaluate British Amer's performance over the market, the standard measures of volatility play an important role as well.

British Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in British Amer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module

British Amer Corporate Directors

David WurzerIndependent DirectorProfile
Mario SaltarelliNon-Executive DirectorProfile
John CurranIndependent DirectorProfile
Aaron EltonDirector MarketingProfile

Additional Tools for British Stock Analysis

When running British Amer's price analysis, check to measure British Amer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy British Amer is operating at the current time. Most of British Amer's value examination focuses on studying past and present price action to predict the probability of British Amer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move British Amer's price. Additionally, you may evaluate how the addition of British Amer to your portfolios can decrease your overall portfolio volatility.